Low-Dose and Slow-Infusion Thrombolysis for Prosthetic Valve Thrombosis After a Transcatheter Valve in the Mitral Position.
Cardiology Department, Imelda Hospitals Bonheiden, Bonheiden, Belgium.
John
J
Roosen
Cardiology Department, Imelda Hospitals Bonheiden, Bonheiden, Belgium; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium. Electronic address: peter.haemers@kuleuven.be.
Peter
P
Haemers
Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Peter
P
Verhamme
Cardiology Department, Imelda Hospitals Bonheiden, Bonheiden, Belgium; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Koen
K
Ameloot
Cardiology Department, Imelda Hospitals Bonheiden, Bonheiden, Belgium; Department of Cardiovascular Sciences, University Hospitals Leuven, Leuven, Belgium.
Herbert
H
De Praetere
D000369:Aged, 80 and over; D006328:Cardiac Catheterization / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D018618:Echocardiography, Doppler, Color; D019560:Echocardiography, Three-Dimensional; D017548:Echocardiography, Transesophageal; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000295:instrumentation / Q000379:methods; D006801:Humans; D007262:Infusions, Intravenous; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D008944:Mitral Valve Insufficiency / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000601:surgery*; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
mitral position; thrombolysis; transcatheter valve